FDA Panel To Review SonaCare’s HIFU Device For Prostate Cancer
This article was originally published in The Gray Sheet
Executive Summary
It will be the second time this year that the Gastroenterology and Urology Devices Panel reviews a high intensity focused ultrasound system intended for prostate cancer. SonaCare is surely hoping for a better showing for its Sonablate 450 than EDAP experienced last month with its Ablatherm HIFU.